Ajou universitiy school of medicine
Suwon, Gyeong-gi Do, 16499, South Korea
NCT Number: NCT02655380
Ketamine and opioid are known to improve the intubating condition, respectively. Combination of ketamine and opioid potentiate analgesic effect and give hemodynamic stability in complementary manner. Therefore, the combination use of ketamine and remifentanil could be useful for acceptable intubating condition in the general anesthesia without the use of neuromuscular blocking agent. Generally, induction dose of ketamine ranges between 1 and 2 mg. There was no report about the optimal dose of remifentanil with 1 or 2 mg ketamine induction dose for intubation without neuromuscular blocking agent. The investigators focus on remifentanil dose using Dixon's up and down method.
Looking for future studies?
Notify Me3 year–12 year
All sexes
Interventional
Phase 4
Suwon, Gyeong-gi Do, 16499, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Anesthesia induction is performed with 1 mg ketamine.
Anesthesia induction is performed with 2 mg ketamine.
After anesthesia induction with ketamine, predetermined remifentanil using Dixon's up and dowm method is administered.
Time frame: during and after intubation, about 2 minute
For assessment of intubation condition, 5 variables will be individually evaluated though 3 point scale (excellent, good, poor). If all variables are graded as excellent, intubation condition will be excellent. If at least 1 variable is poor, it will be reported as poor. Otherwise, it will be reported as good. Good and excellent will be considered to be acceptable intubating condition. Poor will be reported as unacceptable intubating condition.
Ajou University School of Medicine
Other
Remifentanil Requirement for Acceptable Intubating Condition With Two Dose Ketamine Without Neuromuscular Blocking Agent in Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06521749
Intubating Condition
Giza, Giza Governorate, Egypt
View Trial DetailsNCT01479751
Intubating Condition
Seongnam-si, Gyeonggi-do, South Korea
View Trial Details